IOVA FY 2020 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$262M

Net Income

-$260M

EPS (Diluted)

$-1.88

Cash Flow

Operating Cash Flow

-$205M

Free Cash Flow

-$252M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$768M

Total Liabilities

$112M

Stockholders' Equity

$656M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$8M	+100.0%
Operating Income	-$262M	-$207M	-26.6%
Net Income	-$260M	-$198M	-31.4%